Furthermore, IL-37b homogeneous transgenic mice showed a decrease in TSLP expression along with reduced infiltration of basophils, confirming that IL-37 could ameliorate AD by regulating TSLP-mediated basophil activation (Figure 7). This evidence concerns the gene TSLP and Alzheimer disease.